Literature DB >> 21272088

Surgical procedures for benign prostatic hyperplasia: a nationwide survey in Japan.

Naoya Masumori1, Toshiyuki Kamoto, Narihito Seki, Yukio Homma.   

Abstract

We investigated the trend in surgical procedures for benign prostatic hyperplasia (BPH) during the past 10 years in Japan. A questionnaire inquiring about the number of operations and surgical procedures for BPH in 1999, 2004 and 2009 was sent to 1824 institutes belonging to the Japanese Urological Association and/or the Japanese Clinical Urologists Association. Responses were obtained from 767 institutes (42.1%). The number of operations showed a gradual increase during the 10 years (n = 17,221 in 1999, 18,772 in 2004, 20,413 in 2009). Transurethral resection of the prostate, including transurethral resection in saline, was consistently the most common procedure (72.5% to 79.2%). Holmium laser enucleation of the prostate and transurethral enucleation with a bipolar system have dramatically increased, becoming the second most common in 2009 (n = 3416), although enucleation by open prostatectomy was still a viable option in 2009 (n = 555). Photoselective vaporization of the prostate was the third most common method in 2009 (n = 572). Coagulation and thermotherapy have become uncommon (n = 2039 in 1999, 217 in 2009), whereas incision and stenting were unchanged during the period. Thus, surgical procedures for BPH have been increasing in Japan during the past decade. Transurethral resection remains the standard, whereas enucleation and vaporization have been increasing.
© 2010 The Japanese Urological Association.

Entities:  

Mesh:

Year:  2010        PMID: 21272088     DOI: 10.1111/j.1442-2042.2010.02687.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  7 in total

Review 1.  Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Youcheng Lin; Xun Wu; Abai Xu; Rui Ren; Xueqiong Zhou; Yong Wen; Yong Zou; Mancheng Gong; Chunxiao Liu; Zexuan Su; Thomas R W Herrmann
Journal:  World J Urol       Date:  2015-12-23       Impact factor: 4.226

2.  Comparison of outpatient versus inpatient transurethral prostate resection for benign prostatic hyperplasia: Comparative, prospective bi-centre study.

Authors:  Jae Heon Kim; Jae Young Park; Ji Sung Shim; Jeong Gu Lee; Du Geon Moon; Jeong Woo Yoo; Hoon Choi; Jae Hyun Bae
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

3.  In-hospital outcomes and cost assessment between bipolar versus monopolar transurethral resection of the prostate.

Authors:  Toru Sugihara; Hideo Yasunaga; Hiromasa Horiguchi; Mitsuhiro Nakamura; Hiroaki Nishimatsu; Haruki Kume; Kazuhiko Ohe; Shinya Matsuda; Yukio Homma
Journal:  J Endourol       Date:  2012-03-19       Impact factor: 2.942

4.  Comparative Analysis of the Efficacy and Safety of Conventional Transurethral Resection of the Prostate, Transurethral Resection of the Prostate in Saline (TURIS), and TURIS-Plasma Vaporization for the Treatment of Benign Prostatic Hyperplasia: A Pilot Study.

Authors:  Yong Taec Lee; Young Woo Ryu; Dong Min Lee; Sang Wook Park; Seung Hee Yum; June Hyun Han
Journal:  Korean J Urol       Date:  2011-11-17

5.  Patient satisfaction after holmium laser enucleation of the prostate (HoLEP): A prospective cohort study.

Authors:  Young Ju Lee; Shin Ah Oh; Sung Han Kim; Seung-June Oh
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

6.  Multivariate Analysis of the Failure of Removal of the Urinary Catheter within 48 Hours after Transurethral Enucleation and Resection of the Prostate.

Authors:  Yukun Wu; Binshen Chen; Chunxiao Liu
Journal:  Biomed Res Int       Date:  2020-02-13       Impact factor: 3.411

7.  Current surgical procedures for benign prostatic hyperplasia and impression of new surgical modalities.

Authors:  Abdullah M Al Khayal; Faisal K Balaraj; Turki A Alferayan; Khalid A Alrabeeah; Saad M Abumelha
Journal:  Urol Ann       Date:  2021-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.